Randomized phase II placebo controlled study of codrituzumab in previously treated patients with advanced hepatocellular carcinoma

Ghassan K. Abou‐Alfa; Óscar Puig; Bruno Daniele; Masatoshi Kudo; Philippe Merle; Joong‐Won Park; Paul J. Ross; Jean-Marie Péron; Oliver Ebert; Stephen L. Chan; Tung Ping Poon; M. Colombo; Takuji Okusaka; Baek‐Yeol Ryoo; Beatriz Mínguez; Takayoshi Tanaka; Toshihiko Ohtomo; Stacey M. Ukrainskyj; Frédéric Boisserie; Olga Rutman; Ya-Chi Chen; Chao Xu; Eliezer Shochat; Lori Jukofsky; Bernhard Reis; Gong Chen; Laura Di Laurenzio; Ray Lee; Chia-Jui Yen

doi:10.1016/j.jhep.2016.04.004

Related publications

Article2017

KEYNOTE-224: Phase II study of pembrolizumab in patients with previously treated advanced hepatocellular carcinoma.

Andrew X. Zhu, Jennifer J. Knox, Masatoshi Kudo, Stephen L. Chan, Richard S. Finn, Abby B. Siegel, Junshui Ma, P.A. Watson, Ann‐Lii Cheng

Article2016

Pembrolizumab in patients with previously treated advanced hepatocellular carcinoma: Phase 2 KEYNOTE-224 study

Andrew X. Zhu, Jennifer J. Knox, Masatoshi Kudo, Stephen L. Chan, Richard S. Finn, A.B. Siegel, J. Ma, P.A. Watson, Ann‐Lii Cheng

Article2022

Updated efficacy and safety of KEYNOTE-224: a phase II study of pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib

Masatoshi Kudo, Richard S. Finn, Julien Edeline, Stéphane Cattan, Sadahisa Ogasawara, Daniel H. Palmer, Chris Verslype, Vittorina Zagonel, Lætitia Fartoux, Arndt Vogel, Debashis Sarker, Gontran Verset, Stephen L. Chan, Jennifer J. Knox, Bruno Daniele, Thomas Yau, Ellen B. Gurary, Abby B. Siegel, Anran Wang, Ann‐Lii Cheng, Andrew X. Zhu

Article2015

A randomized, double-blind, placebo-controlled phase III study of S-1 in patients with sorafenib-refractory advanced hepatocellular carcinoma (S-CUBE).

Masatoshi Kudo, Michihisa Moriguchi, Kazushi Numata, Hisashi Hidaka, Hironori Tanaka, Masafumi Ikeda, Seiji Kawazoe, Shinichi Ohkawa, Yozo Sato, Takuji Okusaka

Article2007

Randomized phase III trial of sorafenib versus placebo in patients with advanced hepatocellular carcinoma (HCC)

Josep M. Llovet, Serafino Ricci, Vincenzo Mazzaferro, P Hilgard, Jean‐Luc Raoul, Stefan Zeuzem, Melanie Poulin-Costello, M. Moscovici, D. Voliotis, Jordi Bruix

Journal of Clinical Oncology